Dominik Heimann

发表

Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB2) ligand designed for PET studies.

H. de Vries, L. Heitman, B. Wünsch, 2018, European journal of medicinal chemistry.

Bioisosteric replacement of central 1,2,4-oxadiazole ring of high affinity CB2 ligands by regioisomeric 1,3,4-oxadiazole ring.

H. de Vries, L. Heitman, B. Wünsch, 2017, MedChemComm.

Optimization of pharmacokinetic properties by modification of a carbazole-based cannabinoid receptor subtype 2 (CB2) ligand.

H. de Vries, L. Heitman, B. Wünsch, 2018, European journal of medicinal chemistry.